The remote medical monitoring plan can be considered successful if it is sound, effective, cost-effective and practical. The current remote medical monitoring system meets at least three of the four features.
Sound remote medical monitoring technology is conducive to accurate data collection and data input, data accuracy verification and correcting incorrect data. A sophisticated technique would include a timestamp of the input data to avoid reverse padding, forward padding, or other data operations. At present, the remote medical monitoring system for diabetes has reached this standard.
Effective technology can determine process outcome measurement, clinical outcome measurement and patient satisfaction. Firstly, the effectiveness of the automated remote medical monitoring system can be evaluated by measuring the adoption of process results, such as timely foot screening, retinal evaluation, vaccination and laboratory testing. These tests include A1C, glucose, blood lipid of all diabetes patients and other laboratory analytes of selected diabetes patients, including serum creatinine level of metformin users, liver test of statin users, serum potassium of hypertension patients receiving selected blood pressure drugs, and serum fructosamine of some hemoglobin patients. Secondly, the effectiveness of remote medical monitoring project can be evaluated based on the improvement of the objective clinical results, such as the A1C level, the number of hypoglycemic events, the blood glucose variability according to the predetermined formula, or emergency room visits for diabetes related events. Finally, patient satisfaction can also be used to measure the effectiveness of remote medical monitoring plans. User experience can measure patient satisfaction through surveys. Patients' feedback can be classified and the patients' system usage can be determined according to the doctor's instructions. Based on a small amount of data, the current remote medical monitoring system for diabetes can achieve this standard.
TRANSTEK remote medical monitoring is an integral part of remote patient monitoring (RPM) devices that including BP cuff, weight scale, BGM and activity tracker, the measurement data meet needs of reimbursement by CMS.
Compared with basic treatment, cost-effective remote medical monitoring technology will provide benefits for costs. Its costs are either lower than current care (also known as cost saving intervention), or the cost-benefit ratio is better within the scope that society is willing to pay for other widely used services. For each quality adjusted life year benefited, the amount is usually within the cost range of up to $50000. At present, whether the remote medical monitoring system for diabetes meets this standard has not been determined, so they do not have obvious cost-effectiveness.
Founded in 2002, Transtek is committed to multiple health fields such as remote health and chronic disease management, providing customers with medical-grade "RPM devices" and "cloud services". Transtek has established a co-branded solution named TeleRPM since 2022, it stands for Quality & Value which is the best of Transtek. TeleRPM is an integrated solution which includes cellular blood pressure monitor, cellular weight scale, cellular blood glucose meter and all-round BLE package with AnyHub solution.